These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2850449)

  • 41. Herpes simplex virus latency in a hyperresistant clone of mouse neuroblastoma (Cl300) cells.
    Nilheden E; Jeansson S; Vahlne A
    Arch Virol; 1985; 83(3-4):319-25. PubMed ID: 2982359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Persistent replication of herpes simplex virus type 1 in JOK-1 cells.
    Thiele K; Mittnacht S; Kirchner H
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1907-11. PubMed ID: 2544670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A latent infection of herpes simplex virus type 2 in a human neuroblastoma cell line IMR-32.
    Yura Y; Terashima K; Iga H; Yanagawa T; Yoshida H; Hayashi Y; Sato M
    Arch Virol; 1986; 90(3-4):249-60. PubMed ID: 3015082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of dexamethasone on herpes simplex virus replication in mouse neuroblastoma cells (NB41A3): receptor characteristics.
    Dreyer LL; Sydiskis RJ; Bashirelahi N
    J Clin Lab Anal; 1989; 3(4):236-43. PubMed ID: 2547923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An unusual defective genotype derived from herpes simplex virus strain ANG.
    Schröder CH; Stegmann B; Lauppe HF; Kaerner HC
    Intervirology; 1975-1976; 6(4-5):270-84. PubMed ID: 186436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thymidine kinase gene transfer by herpes simplex virus.
    Kraiselburd E
    Bull Cancer; 1976; 63(3):393-8. PubMed ID: 187268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of the virus sequence content and biological properties of cells carrying the herpes simplex virus type 2 thymidine kinase gene.
    Minson A; Bell SE; Bastow K
    J Gen Virol; 1982 Jan; 58 Pt 1():127-38. PubMed ID: 6292338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats.
    Kaplitt MG; Tjuvajev JG; Leib DA; Berk J; Pettigrew KD; Posner JB; Pfaff DW; Rabkin SD; Blasberg RG
    J Neurooncol; 1994; 19(2):137-47. PubMed ID: 7964989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Consequences of herpes simplex virus type 2 and human cell interaction at supraoptimal temperatures.
    Marcon MJ; Kucera LS
    J Virol; 1976 Oct; 20(1):54-62. PubMed ID: 185418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Herpes virus and viral DNA synthesis in ultraviolet light-irradiated cells.
    Coppey J; Nocentini S
    J Gen Virol; 1976 Jul; 32(1):1-15. PubMed ID: 182908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeted expression of herpes simplex virus thymidine kinase in adenovirus-infected cells reduces virus titers upon treatment with ganciclovir in vitro.
    Ibrišimović M; Nagl U; Kneidinger D; Rauch M; Lion T; Klein R
    J Gene Med; 2012 Jan; 14(1):3-19. PubMed ID: 22190534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Replication, latent infection, and reactivation in neuronal culture with a herpes simplex virus thymidine kinase-negative mutant.
    Wilcox CL; Crnic LS; Pizer LI
    Virology; 1992 Mar; 187(1):348-52. PubMed ID: 1310559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of latent thymidine kinase-deficient herpes simplex virus in trigeminal ganglia of mice using the polymerase chain reaction.
    Friedrich A; Kleim JP; Schneweis KE
    Arch Virol; 1990; 113(1-2):107-13. PubMed ID: 2167055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective destruction of gliomas in immunocompetent rats by thymidine kinase-defective herpes simplex virus type 1.
    Jia WW; McDermott M; Goldie J; Cynader M; Tan J; Tufaro F
    J Natl Cancer Inst; 1994 Aug; 86(16):1209-15. PubMed ID: 8040888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Herpes simplex virus-specific hybridoma cells cannot be persistently infected with this virus.
    Eis-Hübinger AM; Friedrich A; Schneweis KE
    Intervirology; 1992; 34(1):13-22. PubMed ID: 1330972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptional activity of the herpes simplex virus genome during establishment, maintenance, and reactivation of in vitro virus latency.
    Scheck AC; Wigdahl B; Rapp F
    Intervirology; 1989; 30(3):121-36. PubMed ID: 2473963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolation and characterisation of herpes simplex virus type 1 mutants which fail to induce dUTPase activity.
    Fisher FB; Preston VG
    Virology; 1986 Jan; 148(1):190-7. PubMed ID: 3002029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene.
    Benedetti S; Dimeco F; Pollo B; Cirenei N; Colombo BM; Bruzzone MG; Cattaneo E; Vescovi A; Didonato S; Colombo MP; Finocchiaro G
    Hum Gene Ther; 1997 Jul; 8(11):1345-53. PubMed ID: 9295129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on the proliferation of herpes simplex virus type 1-transformed and thymidine kinase-deficient mouse cells.
    Bubley G; Crumpacker C; De Clercq E; Schnipper L
    Virology; 1983 Sep; 129(2):490-2. PubMed ID: 6312685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells.
    Huang Q; Liu XZ; Kang CS; Wang GX; Zhong Y; Pu PY
    Cancer Gene Ther; 2010 Mar; 17(3):192-202. PubMed ID: 19851353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.